According to the fifth edition of the WHO Classification of Tumors of the Central Nervous System (WHO CNS5), the detection of this alteration allows the reclassification of an IDH wild-type astrocytoma of grade 2 or 3 into an IDH wild-type glioblastoma [10]. This evidence concerns the gene IDH2 and glioblastoma.